nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00105	0.00107	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GFAP—Parkinson's disease	0.00102	0.00104	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—GRM5—Parkinson's disease	0.00101	0.00102	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00101	0.00102	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTA4—Parkinson's disease	0.00101	0.00102	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.001	0.00101	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000996	0.00101	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000987	0.001	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000986	0.000999	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000946	0.000958	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000942	0.000954	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000915	0.000927	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PLA2G6—Parkinson's disease	0.000908	0.00092	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MAOB—Parkinson's disease	0.000899	0.000911	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000897	0.000909	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.00089	0.000902	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGF20—Parkinson's disease	0.000887	0.000898	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000886	0.000898	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000884	0.000896	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000878	0.00089	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000874	0.000886	CbGpPWpGaD
Montelukast—CYSLTR1—head—Parkinson's disease	0.00086	0.0667	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.00086	0.000871	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000855	0.000867	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000855	0.000867	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.000832	0.000843	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ND3—Parkinson's disease	0.000832	0.000843	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000832	0.000843	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.000829	0.00084	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000825	0.000836	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000824	0.000835	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000823	0.000834	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000818	0.000828	CbGpPWpGaD
Montelukast—CYSLTR1—nervous system—Parkinson's disease	0.000815	0.0633	CbGeAlD
Montelukast—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000814	0.000825	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000814	0.000824	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000803	0.000814	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—INSR—Parkinson's disease	0.000794	0.000804	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00079	0.0008	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MCCC1—Parkinson's disease	0.000787	0.000797	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ND3—Parkinson's disease	0.000787	0.000797	CbGpPWpGaD
Montelukast—CYSLTR1—central nervous system—Parkinson's disease	0.000785	0.0609	CbGeAlD
Montelukast—PTGS1—Metabolism—OMD—Parkinson's disease	0.000783	0.000793	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.000783	0.000793	CbGpPWpGaD
Montelukast—ALOX5—cardiovascular system—Parkinson's disease	0.000769	0.0597	CbGeAlD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000764	0.000774	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.000758	0.000768	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGB—Parkinson's disease	0.00075	0.00076	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000748	0.000758	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000748	0.000758	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000746	0.000756	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000745	0.000754	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.000742	0.000752	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TALDO1—Parkinson's disease	0.00074	0.00075	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—OMD—Parkinson's disease	0.00074	0.00075	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TAC1—Parkinson's disease	0.000735	0.000744	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—DRD1—Parkinson's disease	0.000721	0.00073	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GCH1—Parkinson's disease	0.000708	0.000717	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NDUFB11—Parkinson's disease	0.000702	0.000711	CbGpPWpGaD
Montelukast—SLCO2B1—forebrain—Parkinson's disease	0.0007	0.0543	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—DRD3—Parkinson's disease	0.000698	0.000707	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000675	0.000684	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000672	0.00068	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.00067	0.000679	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GCH1—Parkinson's disease	0.000669	0.000678	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP2D6—Parkinson's disease	0.000668	0.000677	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000666	0.000674	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000662	0.000671	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CTGF—Parkinson's disease	0.000656	0.000664	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000652	0.00066	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000638	0.000647	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR7—Parkinson's disease	0.000631	0.000639	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—DRD2—Parkinson's disease	0.000631	0.000639	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GBA—Parkinson's disease	0.000631	0.000639	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—DBH—Parkinson's disease	0.000631	0.000639	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—FBP1—Parkinson's disease	0.000631	0.000639	CbGpPWpGaD
Montelukast—CYSLTR1—brain—Parkinson's disease	0.000623	0.0484	CbGeAlD
Montelukast—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000617	0.000625	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000616	0.000624	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP2E1—Parkinson's disease	0.000611	0.000619	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000609	0.000617	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NQO1—Parkinson's disease	0.000604	0.000612	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—FBP1—Parkinson's disease	0.000597	0.000604	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—DBH—Parkinson's disease	0.000597	0.000604	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GBA—Parkinson's disease	0.000597	0.000604	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TH—Parkinson's disease	0.000595	0.000603	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000587	0.000595	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000579	0.000587	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYCS—Parkinson's disease	0.000572	0.000579	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000571	0.000578	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000538	0.000545	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000538	0.000545	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000537	0.000544	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00053	0.000537	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF2—Parkinson's disease	0.000529	0.000536	CbGpPWpGaD
Montelukast—ALOX5—head—Parkinson's disease	0.000521	0.0404	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000511	0.000518	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—COMT—Parkinson's disease	0.000506	0.000513	CbGpPWpGaD
Montelukast—SLCO2B1—medulla oblongata—Parkinson's disease	0.000506	0.0393	CbGeAlD
Montelukast—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000506	0.000512	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000506	0.000512	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EDN1—Parkinson's disease	0.000505	0.000512	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTP1—Parkinson's disease	0.000504	0.00051	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MAOA—Parkinson's disease	0.000503	0.000509	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—HMOX1—Parkinson's disease	0.000497	0.000503	CbGpPWpGaD
Montelukast—ALOX5—nervous system—Parkinson's disease	0.000494	0.0383	CbGeAlD
Montelukast—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000479	0.000485	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ABCB1—Parkinson's disease	0.000477	0.000483	CbGpPWpGaD
Montelukast—ALOX5—central nervous system—Parkinson's disease	0.000475	0.0369	CbGeAlD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000465	0.000471	CbGpPWpGaD
Montelukast—ALOX5—cerebellum—Parkinson's disease	0.000465	0.0361	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—NGF—Parkinson's disease	0.000464	0.00047	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTM1—Parkinson's disease	0.000463	0.000469	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—DDC—Parkinson's disease	0.000463	0.000469	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000457	0.000463	CbGpPWpGaD
Montelukast—SLCO2B1—spinal cord—Parkinson's disease	0.000451	0.035	CbGeAlD
Montelukast—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000445	0.000451	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GPX1—Parkinson's disease	0.000443	0.000449	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000443	0.000449	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000442	0.000448	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000442	0.000448	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000439	0.000445	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—DDC—Parkinson's disease	0.000438	0.000444	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000438	0.000443	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000438	0.000443	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000437	0.000443	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000437	0.000443	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000432	0.000437	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTA4—Parkinson's disease	0.000413	0.000419	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000412	0.000418	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000411	0.000417	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000411	0.000417	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APOE—Parkinson's disease	0.000411	0.000416	CbGpPWpGaD
Montelukast—CYP2A6—cerebellum—Parkinson's disease	0.00041	0.0318	CbGeAlD
Montelukast—ALOX5—Metabolism—MTHFR—Parkinson's disease	0.000409	0.000415	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000407	0.000413	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000407	0.000413	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000407	0.000413	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000407	0.000412	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000401	0.000407	CbGpPWpGaD
Montelukast—SLCO2B1—head—Parkinson's disease	0.000401	0.0311	CbGeAlD
Montelukast—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000394	0.000399	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.00039	0.000395	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MAOB—Parkinson's disease	0.00039	0.000395	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—APOE—Parkinson's disease	0.000381	0.000386	CbGpPWpGaD
Montelukast—SLCO2B1—nervous system—Parkinson's disease	0.00038	0.0295	CbGeAlD
Montelukast—ALOX5—brain—Parkinson's disease	0.000377	0.0293	CbGeAlD
Montelukast—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	0.000372	0.000377	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000372	0.000377	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000371	0.000376	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MAOB—Parkinson's disease	0.000369	0.000373	CbGpPWpGaD
Montelukast—SLCO2B1—central nervous system—Parkinson's disease	0.000366	0.0284	CbGeAlD
Montelukast—PTGS1—forebrain—Parkinson's disease	0.000365	0.0283	CbGeAlD
Montelukast—SLCO2B1—cerebellum—Parkinson's disease	0.000358	0.0278	CbGeAlD
Montelukast—CYSLTR1—Signaling Pathways—INS—Parkinson's disease	0.000351	0.000356	CbGpPWpGaD
Montelukast—CYP2C9—cardiovascular system—Parkinson's disease	0.000338	0.0262	CbGeAlD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000336	0.00034	CbGpPWpGaD
Montelukast—CYP2A6—brain—Parkinson's disease	0.000333	0.0258	CbGeAlD
Montelukast—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000332	0.000336	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000332	0.000336	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000332	0.000336	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—INS—Parkinson's disease	0.000325	0.00033	CbGpPWpGaD
Montelukast—PTGS1—cardiovascular system—Parkinson's disease	0.000309	0.024	CbGeAlD
Montelukast—CYP2C8—Metabolism—DDC—Parkinson's disease	0.000299	0.000303	CbGpPWpGaD
Montelukast—SLCO2B1—brain—Parkinson's disease	0.000291	0.0225	CbGeAlD
Montelukast—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.00029	0.000293	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000289	0.000292	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000289	0.000292	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000284	0.000288	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.000282	0.000286	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000279	0.000282	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	0.000274	0.000277	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000271	0.000275	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000271	0.000275	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CTGF—Parkinson's disease	0.000269	0.000272	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000265	0.000268	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000262	0.000265	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—Parkinson's disease	0.000261	0.000265	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—Parkinson's disease	0.00026	0.000263	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TH—Parkinson's disease	0.000258	0.000262	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000257	0.000261	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000254	0.000258	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000252	0.000255	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	0.000251	0.000254	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000248	0.000251	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NQO1—Parkinson's disease	0.000248	0.000251	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000245	0.000249	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TH—Parkinson's disease	0.000244	0.000247	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000243	0.000247	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK8—Parkinson's disease	0.00024	0.000243	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00024	0.000243	CbGpPWpGaD
Montelukast—PTGS1—spinal cord—Parkinson's disease	0.000235	0.0183	CbGeAlD
Montelukast—CYP2A6—Metabolism—CYCS—Parkinson's disease	0.000234	0.000237	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.00023	0.000233	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000227	0.00023	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—COMT—Parkinson's disease	0.00022	0.000222	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000219	0.000222	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000219	0.000222	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000219	0.000222	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000218	0.000221	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000218	0.000221	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000215	0.000218	CbGpPWpGaD
Montelukast—PTGS1—head—Parkinson's disease	0.000209	0.0162	CbGeAlD
Montelukast—CYP2A6—Metabolism—COMT—Parkinson's disease	0.000208	0.00021	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000207	0.00021	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000207	0.00021	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—Parkinson's disease	0.000207	0.000209	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MAOA—Parkinson's disease	0.000206	0.000209	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000205	0.000208	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—Parkinson's disease	0.000204	0.000206	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000201	0.000203	CbGpPWpGaD
Montelukast—PTGS1—nervous system—Parkinson's disease	0.000198	0.0154	CbGeAlD
Montelukast—CYP2A6—Metabolism—ABCB1—Parkinson's disease	0.000196	0.000198	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000195	0.000198	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000192	0.000195	CbGpPWpGaD
Montelukast—PTGS1—central nervous system—Parkinson's disease	0.000191	0.0148	CbGeAlD
Montelukast—CYP2A6—Metabolism—GSTM1—Parkinson's disease	0.00019	0.000192	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000187	0.00019	CbGpPWpGaD
Montelukast—CYP2C8—brain—Parkinson's disease	0.000187	0.0145	CbGeAlD
Montelukast—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.000184	0.000186	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—Parkinson's disease	0.000182	0.000184	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000177	0.00018	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	0.000171	0.000173	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NQO1—Parkinson's disease	0.000169	0.000171	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—Parkinson's disease	0.000168	0.00017	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TH—Parkinson's disease	0.000167	0.000169	CbGpPWpGaD
Montelukast—CYP3A4—nervous system—Parkinson's disease	0.000166	0.0128	CbGeAlD
Montelukast—PTGS1—Metabolism—APOE—Parkinson's disease	0.000165	0.000167	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000161	0.000163	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYCS—Parkinson's disease	0.00016	0.000162	CbGpPWpGaD
Montelukast—CYP3A4—central nervous system—Parkinson's disease	0.000159	0.0124	CbGeAlD
Montelukast—CYP2A6—Metabolism—APOE—Parkinson's disease	0.000156	0.000158	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—Parkinson's disease	0.000153	0.000155	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000152	0.000154	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000152	0.000154	CbGpPWpGaD
Montelukast—PTGS1—brain—Parkinson's disease	0.000151	0.0118	CbGeAlD
Montelukast—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000149	0.000151	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—COMT—Parkinson's disease	0.000142	0.000144	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—Parkinson's disease	0.000141	0.000143	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INS—Parkinson's disease	0.000141	0.000143	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MAOA—Parkinson's disease	0.000141	0.000143	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000139	0.000141	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—Parkinson's disease	0.000139	0.000141	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000138	0.00014	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000136	0.000138	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TH—Parkinson's disease	0.000136	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000135	0.000137	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—Parkinson's disease	0.000134	0.000135	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INS—Parkinson's disease	0.000133	0.000135	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.00013	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—Parkinson's disease	0.00013	0.000131	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—Parkinson's disease	0.000124	0.000126	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—COMT—Parkinson's disease	0.000115	0.000117	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—Parkinson's disease	0.000115	0.000116	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—Parkinson's disease	0.000115	0.000116	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MAOA—Parkinson's disease	0.000115	0.000116	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—Parkinson's disease	0.000113	0.000115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—Parkinson's disease	0.000109	0.00011	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—Parkinson's disease	0.000107	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—Parkinson's disease	0.000106	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—Parkinson's disease	0.000101	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.0001	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.86e-05	9.99e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.33e-05	9.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.18e-05	9.3e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INS—Parkinson's disease	9.12e-05	9.23e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.08e-05	9.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TH—Parkinson's disease	8.95e-05	9.07e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—Parkinson's disease	8.68e-05	8.8e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.59e-05	8.71e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—COMT—Parkinson's disease	7.61e-05	7.71e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.57e-05	7.67e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.56e-05	7.66e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.47e-05	7.57e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INS—Parkinson's disease	7.42e-05	7.52e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.17e-05	7.26e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.96e-05	7.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.67e-05	6.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.15e-05	6.23e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—Parkinson's disease	5.73e-05	5.8e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INS—Parkinson's disease	4.89e-05	4.96e-05	CbGpPWpGaD
